Jordan

Jordan has emerged as a premier pharmaceutical manufacturing hub in the Middle East, renowned for its sophisticated production of generic drugs and a growing focus on biosimilars.

The nation’s life sciences ecosystem is anchored by a robust healthcare infrastructure, making it a top-tier destination for medical tourism and specialized clinical services.

The biotechnology sector is rapidly expanding, fueled by intensive academic research and high-ranking institutions like the University of Jordan, which places in the top 50 globally for pharmacy & pharmacology.

International investors are increasingly drawn to Jordan’s high-value manufacturing capabilities and strategic investment incentives offered within its specialized development zones.

The country’s commitment to digital health is evident through the national scale-up of the Hakeem Electronic Health Records program, streamlining patient data across the healthcare delivery network.

Collaborative R&D partnerships between private enterprises and academic labs are driving breakthroughs in clinical trials and medical device development.

As a signatory to various free trade agreements, Jordan provides a seamless gateway for biopharmaceutical exports to global markets.

This dynamic environment, supported by a highly skilled workforce of scientists and clinicians, solidifies Jordan's status as a critical node in the global life sciences supply chain.